Report Description
The UAE Artificial Organs & Bionic Implants Market size was valued at USD XX Billion in 2022 and is expected to surpass USD XX Billion by 2031, expanding at a CAGR of 11.48% during the forecast period, 2023 – 2031. The growth of the market is attributed to increasing accidents and road injuries and the rising incidence of disabilities and organ failure. Furthermore, the technological advancements and the increasing healthcare expenditure in the region are boosting the market growth.
Artificial organs and bionics refers to man-made devices that can be integrated or implanted into humans, to either replace a natural organ or provide support for the purpose of restoring specific function or a group of related functions, helping the patient to sustain a normal life.
As per Dubai Health Authority (DHA), 2019, UAE has high prevalence of diabetes; the prevalence of diabetes is anticipated to rise to more than 21.5%. The key factors responsible for the amputations are due to diabetic foot ulcers. More than half of all foot ulcers (wounds) are expected to become infected, requiring hospitalization, and 20% of infections were expected to result in amputation.
The Covid-19 pandemic had a positive impact on the UAE artificial organs & bionic implants market. According to World Health Organisation (WHO) the Covid-19 pandemic has impacted and surged the demand artificial organs & bionic implants. It has generated immense opportunity for the market. Also government’s support in developing such technologies is expected to boost the global market of UAE artificial organs & bionic implants.
Market Trends, Drivers, Restraints, and Opportunities
-
Growing incidence of organ failure and disabilities are expected to drive the market during the forecast period.
-
Increasing number of accidents and road injuries are estimated to propel the market in coming years.
-
Rising prevalence of diabetes among population is likely to surge the artificial organs & bionic implants market.
-
High cost associated with organs and the procedures are expected to impede the market.
-
Fear of device malfunction and its consequences is hindering the artificial organs and bionic implants market in the country.
-
R&D investment and technological advancement in the UAE artificial organs & bionic implants market are expected to offer lucrative opportunities for the market players.
Scope of the Report
The report on the UAE artificial organs & bionic implants market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes
|
Details
|
Report Title
|
UAE Artificial Organs & Bionic Implants Market –Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
Base Year
|
2022
|
Historic Data
|
2016
|
Forecast Period
|
2023–2031
|
Segmentation
|
Product (Artificial Organs [Artificial Heart, Artificial Kidney, Cochlear Implants, and Others], Bionics [Vision Bionics, Ear Bionics, Orthopedic Bionic, Cardiac Bionics, and Others])
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
Key Players Covered in the Report
|
Boston Scientific Corporation; Medtronic plc; Zimmer Biomet; Otto Bock Holding GmbH & Co. KG; and Edwards Lifesciences Corporation.
|
Market Segment insights
The orthopedic bionic segment is projected to constitute a large market share
Based on product, the artificial organs & bionic implants market is segregated into artificial organs, bionics. The artificial organ segment is further divided into artificial heart, artificial kidney, cochlear implants, and others and the bionics segment is further divided into vision bionics, ear bionics, orthopedic bionic, cardiac bionics, and others. The orthopedic bionic segment is expected to account for a key share of the market during the forecast period owing to increasing prevalence of road accidents and injuries, which is increasing the demand for artificial limbs and other bionics. Furthermore, increasing geriatric population who are in need of total joints replacement and knee replacement is also fueling the segment growth.
Segments
The UAE artificial organs & bionic implants market has been segmented on the basis of:-
Product
- Artificial Organs
- Artificial Heart
- Artificial Kidney
- Cochlear Implants
- Others
- Bionics
- Vision Bionics
- Ear Bionics
- Orthopedic Bionic
- Cardiac Bionics
- Others
Key Companies
- Boston Scientific Corporation
- Medtronic plc
- Zimmer Biomet
- Otto Bock Holding GmbH & Co. KG
- Edwards Lifesciences Corporation
Competitive Landscape
Key players competing in the UAE artificial organs & bionic implants market include Boston Scientific Corporation; Medtronic plc; Zimmer Biomet; Otto Bock Holding GmbH & Co. KG; and Edwards Lifesciences Corporation.
Some of these players are using several market strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market shares.

Table Of Content
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Artificial Organs & Bionic Implants Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Artificial Organs & Bionic Implants Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Artificial Organs & Bionic Implants Market - Supply Chain
4.5. Global Artificial Organs & Bionic Implants Market Forecast
4.5.1. Artificial Organs & Bionic Implants Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Artificial Organs & Bionic Implants Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Artificial Organs & Bionic Implants Market Absolute $ Opportunity
5. Global Artificial Organs & Bionic Implants Market Analysis and Forecast by End Users
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by End Users
5.2.2. Y-o-Y Growth Projections by End Users
5.3. Artificial Organs & Bionic Implants Market Size and Volume Forecast by End Users
5.3.1. Boston Scientific Corporation
5.3.2.
Medtronic plc
5.3.3.
Zimmer Biomet
5.3.4.
Otto Bock Holding GmbH & Co. KG
5.3.5.
Edwards Lifesciences Corporation
5.4. Absolute $ Opportunity Assessment by End Users
5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Artificial Organs & Bionic Implants Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Artificial Organs & Bionic Implants Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
7. North America Artificial Organs & Bionic Implants Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Artificial Organs & Bionic Implants Market Size and Volume Forecast by End Users
7.4.1. Boston Scientific Corporation
7.4.2.
Medtronic plc
7.4.3.
Zimmer Biomet
7.4.4.
Otto Bock Holding GmbH & Co. KG
7.4.5.
Edwards Lifesciences Corporation
7.5. Basis Point Share (BPS) Analysis by End Users
7.6. Y-o-Y Growth Projections by End Users
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
8. Latin America Artificial Organs & Bionic Implants Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Artificial Organs & Bionic Implants Market Size and Volume Forecast by End Users
8.4.1. Boston Scientific Corporation
8.4.2.
Medtronic plc
8.4.3.
Zimmer Biomet
8.4.4.
Otto Bock Holding GmbH & Co. KG
8.4.5.
Edwards Lifesciences Corporation
8.5. Basis Point Share (BPS) Analysis by End Users
8.6. Y-o-Y Growth Projections by End Users
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
9. Europe Artificial Organs & Bionic Implants Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Artificial Organs & Bionic Implants Market Size and Volume Forecast by End Users
9.4.1. Boston Scientific Corporation
9.4.2.
Medtronic plc
9.4.3.
Zimmer Biomet
9.4.4.
Otto Bock Holding GmbH & Co. KG
9.4.5.
Edwards Lifesciences Corporation
9.5. Basis Point Share (BPS) Analysis by End Users
9.6. Y-o-Y Growth Projections by End Users
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
10. Asia Pacific Artificial Organs & Bionic Implants Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Artificial Organs & Bionic Implants Market Size and Volume Forecast by End Users
10.4.1. Boston Scientific Corporation
10.4.2.
Medtronic plc
10.4.3.
Zimmer Biomet
10.4.4.
Otto Bock Holding GmbH & Co. KG
10.4.5.
Edwards Lifesciences Corporation
10.5. Basis Point Share (BPS) Analysis by End Users
10.6. Y-o-Y Growth Projections by End Users
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
11. Middle East & Africa Artificial Organs & Bionic Implants Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Artificial Organs & Bionic Implants Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Artificial Organs & Bionic Implants Market Size and Volume Forecast by End Users
11.4.1. Boston Scientific Corporation
11.4.2.
Medtronic plc
11.4.3.
Zimmer Biomet
11.4.4.
Otto Bock Holding GmbH & Co. KG
11.4.5.
Edwards Lifesciences Corporation
11.5. Basis Point Share (BPS) Analysis by End Users
11.6. Y-o-Y Growth Projections by End Users
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Artificial Organs & Bionic Implants Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Artificial Organs & Bionic Implants Market: Market Share Analysis
12.2. Artificial Organs & Bionic Implants Distributors and Customers
12.3. Artificial Organs & Bionic Implants Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)